The Enterprise Value as of September 2024 (TTM) for Achieve Life Sciences, Inc. (ACHV) is 154.33M

According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 154.33M. This represents a change of 51.27% compared to the average of 102.02M of the last 4 quarters.

Achieve Life Sciences, Inc. (ACHV) Historical Enterprise Value (quarterly & annually)

How has ACHV Enterprise Value performed in the past?

The mean historical Enterprise Value of Achieve Life Sciences, Inc. over the last ten years is 10.19M. The current 154.33M Enterprise Value has changed 151.30% with respect to the historical average. Over the past ten years (40 quarters), ACHV's Enterprise Value was at its highest in in the June 2024 quarter at 166.93M. The Enterprise Value was at its lowest in in the December 2019 quarter at -10576844.60.

Achieve Life Sciences, Inc. (ACHV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Achieve Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Achieve Life Sciences, Inc. (ACHV) Average Enterprise Value

How has ACHV Enterprise Value performed in the past?

The current Enterprise Value of Achieve Life Sciences, Inc. (ACHV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Achieve Life Sciences, Inc. (ACHV) Enterprise Value vs. Peers

How is ACHV’s Enterprise Value compared to its peers?

Achieve Life Sciences, Inc.’s Enterprise Value is less than VectivBio Holding AG (848.58M), less than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (4.49B), less than iTeos Therapeutics, Inc. (186.84M), less than TScan Therapeutics, Inc. (155.10M), less than Day One Biopharmaceuticals, Inc. (975.18M), greater than Acumen Pharmaceuticals, Inc. (113.46M), greater than X4 Pharmaceuticals, Inc. (50.91M), less than Inozyme Pharma, Inc. (407.88M), greater than Immix Biopharma, Inc. (27.90M), greater than CNS Pharmaceuticals, Inc. (3.47M), greater than Hepion Pharmaceuticals, Inc. (2.04M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), greater than NextCure, Inc. (21.40M), greater than CytomX Therapeutics, Inc. (63.80M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (14.38M), greater than Assembly Biosciences, Inc. (95.68M), greater than Bolt Biotherapeutics, Inc. (37.21M), less than Coherus BioSciences, Inc. (259.50M), less than Gracell Biotechnologies Inc. (5.46B),

Build a custom stock screener for Achieve Life Sciences, Inc. (ACHV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achieve Life Sciences, Inc. (ACHV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.